Technology

NCRM
Started in September 2005 as a unit of Nichi-In Bio Sciences Pvt Ltd.,
(Major investor: Mr Morozumi Yoshio, MD, Kyowa Inc, Japan)
Till date has achieved the following in India:
1. The Pioneers for Immunotherapy for Cancer treatment, The Pioneers for Stem cell therapy for Diabetic ischemic foot, The Pioneers for successful stem cell therapy for spinal cord injury in India
2. Till date more than 100 patients were treated by Stem Cell Therapy.
3. Have two publications and presented more than 10 clinical presentations in International meetings.
4. Seven collaborations in India for both research & clinical applications
5. TWO patents on stem cells / Regenerative Medicine (Applied)
6. The holding company has been listed as one of the 107 companies in the world and one of the 2 in India with very good potentials in Regenerative Medicine.

GN Corporation Ltd of Japan
GN Corporation’s (Japan) Rights of Distribution and Technical collaboration with:
1. Biotherapy Institute of Japan (Immunotherapy for Cancers)
2. Nichi In Center for Regenerative Medicine (NCRM) Chennai, India for Stem Cell Treatments and Research and Development .
More Information visit www.gncorporation.com